报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 1.11% | -69.67% | 214.43% | 94/129 | 4.79% | 迈瑞医疗 | 28.68% | 行业排名> |
2024-06-30 | -0.97% | -191.51% | 47.57% | 109/129 | 3.05% | 迈瑞医疗 | 20.2% | 行业排名> |
2024-03-31 | -1.85% | -76.19% | -134.64% | 119/129 | 1.68% | 迈瑞医疗 | 9.12% | 行业排名> |
2023-12-31 | 5.34% | -9.64% | 45.9% | 65/129 | 5.06% | 迈瑞医疗 | 33.21% | 行业排名> |
2023-09-30 | 3.66% | -5.18% | 245.28% | 78/129 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
2023-06-30 | 1.06% | 10.42% | 200.95% | 96/129 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
2023-03-31 | -1.05% | -50% | -117.77% | 116/129 | 2.29% | 安杰思 | 8.56% | 行业排名> |
2022-12-31 | 5.91% | -58.47% | 53.11% | 87/129 | 13.44% | 九安医疗 | 146.56% | 行业排名> |
2022-09-30 | 3.86% | -34.8% | 302.08% | 92/129 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
2022-06-30 | 0.96% | -28.36% | 237.14% | 106/129 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
2022-03-31 | -0.7% | 2% | -104.92% | 103/129 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
2021-12-31 | 14.23% | 35.52% | 140.37% | 59/129 | 17.49% | 热景生物 | 121.78% | 行业排名> |
2021-09-30 | 5.92% | 2% | 341.79% | 87/129 | 15.94% | 热景生物 | 99.69% | 行业排名> |
2021-06-30 | 1.34% | -49.05% | -87.24% | 109/129 | 11.54% | 热景生物 | 99.09% | 行业排名> |
2020-12-31 | 10.5% | -21.29% | 299.24% | 86/129 | 25.82% | 热景生物 | 57.63% | 行业排名> |
2020-06-30 | 2.63% | 2% | -80.28% | 92/129 | 15.16% | 中红医疗 | 168% | 行业排名> |
2019-12-31 | 13.34% | 85.79% | 85.79% | 60/129 | 14.38% | 圣湘生物 | 112.46% | 行业排名> |
2018-12-31 | 7.18% | 88.45% | 88.45% | 80/129 | 12.98% | 博拓生物 | 108.13% | 行业排名> |
2017-12-31 | 3.81% | 2% | 2% | 84/129 | 13.82% | 圣湘生物 | 29.33% | 行业排名> |